Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-1539 (miR-1539) is a human microRNA, a short non-coding RNA (approximately 21 nucleotides in length) involved in the post-transcriptional regulation of gene expression through binding to target mRNAs, resulting in their silencing or degradation. Recent studies highlight its upregulation in exosomes and tissues of colorectal cancer patients, with its expression correlating with markers of tumor proliferation and angiogenesis such as Ki-67 and VEGF. Emerging research supports its potential utility as a sensitive, minimally invasive biomarker for colorectal cancer screening and prognosis, with additional reports suggesting possible roles in other diseases; however, its broader biological function and target genes remain incompletely characterized[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA-1539 (miR-1539).